Cancer discovery

Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.

Cancer discovery

Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji AF, Schreiber SL, Krogan NJ, Shokat KM, McCormick F, Goga A, Bandyopadhyay S

Social interactomes for enabling research communities.

Cancer discovery

Guinney J, Dienstmann R, Ferté C, Friend S, McCormick F

Social interactomes for enabling research communities.

Cancer discovery

Guinney J, Dienstmann R, Ferté C, Friend S, McCormick F

Development of siRNA payloads to target KRAS-mutant cancer.

Cancer discovery

Yuan TL, Fellmann C, Lee CS, Ritchie CD, Thapar V, Lee LC, Hsu DJ, Grace D, Carver JO, Zuber J, Luo J, McCormick F, Lowe SW

Development of siRNA payloads to target KRAS-mutant cancer.

Cancer discovery

Yuan TL, Fellmann C, Lee CS, Ritchie CD, Thapar V, Lee LC, Hsu DJ, Grace D, Carver JO, Zuber J, Luo J, McCormick F, Lowe SW

Soil amendments that slow cancer growth.

Cancer discovery

Isacke CM, Barcellos-Hoff MH

Soil amendments that slow cancer growth.

Cancer discovery

Isacke CM, Barcellos-Hoff MH

An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.

Cancer discovery

Murugaesu N, Iravani M, van Weverwijk A, Ivetic A, Johnson DA, Antonopoulos A, Fearns A, Jamal-Hanjani M, Sims D, Fenwick K, Mitsopoulos C, Gao Q, Orr N, Zvelebil M, Haslam SM, Dell A, Yarwood H, Lord CJ, Ashworth A, Isacke CM

Pages